BCBS Louisiana Medical Policy Updates – September 2018

September 2018 BCBS Louisiana Medical Policy Updates:

• Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
• Angiotensin II Receptor Blockers and Angiotensin II Receptor Blocker Combination Drugs
• Artificial Intervertebral Disc: Cervical Spine
• Artificial Intervertebral Disc: Lumbar Spine
• Basal Insulin/Glucagon Like Peptide (GLP)-1 Agonist Combination Products
• BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
• Botulinum Toxins
• BRAF Gene Mutation Testing to Select Melanoma or Glioma Patients for Targeted Therapy
• Branded Bupropion Products
• Branded Gabapentin Products
• buprenorphine (sublingual)
• Computer-Aided Evaluation of Malignancy with Magnetic Resonance Imaging of the Breast
• Cooling Devices Used in the Outpatient Setting
• Cytochrome p450 Genotyping
• Diagnosis and Management of Idiopathic Environmental Intolerance (i.e., Multiple Chemical Sensitivities)
• Elective Delivery of Pregnancy
• End-Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema
• Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
• Gene Expression-Based Assays for Cancers of Unknown Primary
• Genetic Testing for FMR1 Mutations (Including Fragile X Syndrome)
• Genetic Testing for Mental Health Conditions
• Genetic Testing for Statin Induced Myopathy
• Genetic Testing for Warfarin Dose
• Inhaled Antibiotics for Cystic Fibrosis (tobramycin, Tobi, Tobi Podhaler, Bethkis, Cayston)
• Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)
• Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients With Cancer
• Laser Treatment of Onychomycosis
• Lysis of Epidural Adhesions
• Medical Management of Obstructive Sleep Apnea Syndrome
• Microprocessor-Controlled Prostheses for the Lower Limb
• modafinil (Provigil)/armodafinil (Nuvigil)
• Molecular Testing in the Management of Pulmonary Nodules
• Navigated Transcranial Magnetic Stimulation
• Oravig (miconazole buccal tablets)
• Polysomnography for Non-Respiratory Sleep Disorders
• Proteogenomic Testing for Patients With Cancer (GPS Cancer Test)
• Rayos (prednisone delayed release tablets)
• Repository Corticotropin Injection (ACTH Gel, H.P. Acthar Gel)
• sapropterin dihydrochloride (Kuvan)
• Screening for Lung Cancer Using Computed Tomography Scanning
• Sedative Hypnotics
• Select Antiherpetic Agents (topical, buccal)
• Select Cyclobenzaprine Products
• Selective Serotonin Reuptake Inhibitors (SSRIs)/Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
• Sphenopalatine Ganglion Block for Headache
• Spinal Cord Stimulation
• Subtalar Arthroereisis
• Temporomandibular Joint Dysfunction
• Transcatheter Aortic Valve Implantation for Aortic Stenosis
• Transcatheter Pulmonary Valve Implantation

Click here to view the Blue Cross Blue Shield Louisiana Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.